Abstract:Abstract Background There is an increasing incidence of community-acquired Clostridioides difficile infection (CDI), particularly in IBD. Due to a suspected community outbreak in mid-2023, we aimed to investigate the microbiological and antibiotic resistance profile of CDI in an IBD cohort, employing blind central reading, in order to better understand its epidemiology. Methods This was a prospective study of a University Tertiary Hospital in collaboration with the Infection Control Unit and a central laboratory at the forefront of Infectious Diseases investigation in Portugal (Instituto Ricardo Jorge [IRJ]). Faecal samples from all IBD-related CDI from Apr to Oct 2023, were analysed at IRJ, including isolation and identification of C. difficile strains and testing for antimicrobial susceptibility. Infectious diseases investigators were blinded to patients’ data. Results Eleven patients with IBD (median 42 years, 60.0% female) had at least one episode of CDI, comprising 15 IBD-related CDI cases, which represents 26.3% of all CDI cases in this 6-month period. Moreover, this compares to only 14 cases of IBD-related CDI in the previous four years combined. All patients had UC (66.7% extensive), with a median diagnosis of 11 years. All cases were community-acquired, diagnosed in the context of acute worsening of UC symptoms; 40% required hospitalization. Remarkably, only 2 patients had recent antibiotic therapy, while 3 had a recent visit to the emergency department. No predominant ribotype (RT) was recognised: RT 002/2, RT 017, RT 039, RT 078, RT 106 and RT 839 were identified in similar proportions. There were two new RTs detected, which are under characterization. All isolates were susceptible to vancomycin and metronidazole, but 46.7% were resistant to moxifloxacin, which is higher than ever reported in Portugal. Most cases (n=12) were prescribed vancomycin and followed a taper-and-pulse dosing (n=9). None of the three patients who had a recurrence had received taper-and-pulse dosing. Optimization of UC therapy was performed in all cases, including concomitant immunosuppressive therapy escalation when needed, as recommended. Interestingly, one case, despite having tested positive for C. difficile, had a Clostridioides hathewayi isolated in the culture instead. To our knowledge, this is the first case of C. hathewayi associated diarrhoea resolving upon treatment with vancomycin. Conclusion The absence of a predominant ribotype, excluding a community outbreak, demands heightened CDI vigilance in IBD even in absence of traditional risk factors. Alarming moxifloxacin resistance underscores evolving dynamics. A novel C. hathewayi-associated diarrhoea case and the emergence of two new ribotypes adds complexity.

Molecular Characterization and Antibiotic Resistance of Clostridioides Difficile in Patients with Inflammatory Bowel Disease from Two Hospitals in China

Molecular Epidemiology and Antimicrobial Susceptibility of Clostridium Difficile Isolated from Hospitals During a 4-Year Period in China.

Molecular Epidemiology of Clostridium Difficile in A Tertiary Hospital of China

Epidemiological and clinical characteristics of Clostridium difficile infection in patients with refractory inflammatory bowel disease

Molecular Epidemiology and Clinical Characteristics of Clostridioides Difficile Infection in Patients with Inflammatory Bowel Disease from a Teaching Hospital

Impacts of Infection with Different Toxigenic Clostridium Difficile Strains on Faecal Microbiota in Children.

Molecular epidemiology and clinical characteristics of <i>Clostridioides difficile</i> infection in patients with inflammatory bowel disease from a teaching hospital

Clinical Risk Factors For Clostridium Difficile Infection In A Chinese Tertiary Care Hospital

Molecular Characterization and Antibiotic Profile of Clostridium Difficile Isolated from Bacteremia

Identification of key taxa that favor intestinal colonization of Clostridium difficile in an adult Chinese population

Molecular epidemiological analysis of Clostridium difficile infection in patients with inflammatory bowel disease

Antibiotic Resistances and Molecular Characteristics of <i>Clostridioides difficile</i> in ICUs in a Teaching Hospital From Central South China

Antibiotic Resistances and Molecular Characteristics of Clostridioides difficile in ICUs in a Teaching Hospital From Central South China

Clinical characteristics of community-onset Clostridioides difficile infections at a tertiary hospital in mainland China: A fourteen-year (2010-2023) retrospective study

Antimicrobial Susceptibility and Resistance Mechanisms of Clinical Clostridium Difficile from a Chinese Tertiary Hospital

P1239 Characterization of Clostridioides strains and antibiotic resistance profile in Inflammatory Bowel Disease patients with Clostridioides infection

IDDF2023-ABS-0233 The study of molecular pathogenesis of pediatric clostridiodes difficile infection

Hospital-acquired Clostridium difficile infection in Mainland China: A seven-year (2009–2016) retrospective study in a large university hospital

Characteristics and Management of Children with Clostridioides Difficile Infection at a Tertiary Pediatric Hospital in China.

Molecular characteristics, clonal transmission, and risk factors of Clostridioides difficile among hospitalized patients in a tertiary hospital in Ningbo, China

MICROBIOLOGY, MOLECULAR AND CLINICAL CHARACTERISTICS OF CLOSTRIDIOIDES DIFFICILE INFECTION AND IDENTIFICATION OF RISK FACTORS IN A CHINESE HOSPITAL